Company / Gross Margin
ClearPoint Neuro, Inc. Gross Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
61.4%
FY2025
5-year range
56.8% / 68.2%
FY2021-FY2025
Trend
+8.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 56.8% to 61.4% over the past 2 years.
Based on SEC 10-K filings.
61.4% in FY2025 with a 5-year CAGR of -9.7%.
Improved from 56.8% to 61.4% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -4.5pp
- 5-Year Change
- -9.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin increased 8.0% year-over-year.
- Peak gross margin was recorded in FY2020.
- Lowest gross margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.71 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 61.4% | +8.0% |
| FY2024 | 56.8% | +0.0% |
| FY2023 | 56.8% | -13.7% |
| FY2022 | 65.8% | -3.5% |
| FY2021 | 68.2% | -4.0% |
| FY2020 | 71.1% | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026